Raymond C. Egan
Nessuna posizione attualmente
Profilo
Raymond C.
Egan founded eMedguides.com, Inc., where he worked as Chairman.
Mr. Egan also formerly worked at Mirati Therapeutics, Inc., as Chairman from 2000 to 2010, Bristol Myers Squibb Co., as SVP-Healthcare Policy & New Business Development, Mead Johnson International Ltd., as President & General Manager, and Bristol Laboratories, Inc., as President & General Manager.
Mr. Egan received his Masters Business Admin degree from Syracuse University and undergraduate degree from Trinity College (Connecticut).
Precedenti posizioni note di Raymond C. Egan
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Presidente | 25/08/2010 |
| Bristol Laboratories, Inc. | Presidente | - |
| Mead Johnson International Ltd. | Presidente | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
eMedguides.com, Inc.
 eMedguides.com, Inc. Internet Software/ServicesTechnology Services eMedguides.com, Inc. provides an online and in-print internet directory for medical professionals. The company was founded by Daniel Goldenson and Raymond C. Egan and is headquartered in Princeton, NJ. | Fondatore | - |
Formazione di Raymond C. Egan
| Syracuse University | Masters Business Admin |
| Trinity College (Connecticut) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 4 |
|---|---|
eMedguides.com, Inc.
eMedguides.com, Inc. Internet Software/ServicesTechnology Services eMedguides.com, Inc. provides an online and in-print internet directory for medical professionals. The company was founded by Daniel Goldenson and Raymond C. Egan and is headquartered in Princeton, NJ. | Technology Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
| Mead Johnson International Ltd. | |
| Bristol Laboratories, Inc. |
- Borsa valori
- Insiders
- Raymond C. Egan
